Drugs

HORSHAM, PA, September 30, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved Simponi Aria (golimumab) for patients 2 years of age and older for the treatment of active pJIA and has extended the PsA indication for this same patient population. “This

PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with unresectable malignant pleural

Print this page BOSTON–(BUSINESS WIRE)–Sep. 25, 2020– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved Kalydeco (ivacaftor) for use in children with cystic fibrosis (CF) ages four months to less than six months old who have at least one mutation in their cystic fibrosis transmembrane conductance regulator (CFTR)

Print this page KING OF PRUSSIA, PA  – September 28, 2020 – CSL Behring, a global biotherapeutics leader, announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Haegarda® (C1 Esterase Inhibitor Subcutaneous [Human]) for routine prophylaxis to prevent hereditary angioedema (HAE) attacks in patients 6 years of age

Researchers investigated whether an EEG sleep test for dementia can help to identify individuals with or at risk of developing the condition. Dementia, a brain disease that causes a progressive decline in memory, thought processing, behaviour and everyday functioning, is an increasing problem worldwide. Usually affecting older adults, the condition not only leads to disability

Print this page OSAKA, Japan & FLORHAM PARK, N.J.–(BUSINESS WIRE) September 28, 2020 –Shionogi & Co., Ltd. (hereafter “Shionogi”) today announces that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Fetroja® (cefiderocol) for the treatment of patients 18 years of age or older with hospital-acquired bacterial pneumonia

Treatment for Molybdenum Cofactor Deficiency (MoCD) Type A BridgeBio Pharma And Affiliate Origin Biosciences Announces FDA Acceptance Of Its New Drug Application For Fosdenopterin For The Treatment Of MoCD Type A Print this page SAN FRANCISCO, September 29, 2020 – BridgeBio Pharma, Inc. (Nasdaq: BBIO) and affiliate Origin Biosciences today announced the US Food and

FDA Approves Alkindi Sprinkle (hydrocortisone oral granules) for Pediatric Adrenocortical Insufficiency Print this page DEER PARK, Ill., Sept. 29, 2020 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved

Researchers compared sodium glucose transporter 2 (SGLT2) inhibitors to DPP-4 inhibitors. According to the American Heart Association, people that suffer from diabetes are two to four times more likely to die from heart disease as those without it. Diabetics are more likely to have high blood pressure, cholesterol, body weight, and blood sugar, all of

How effective are household fabrics at preventing the spread of COVID-19? The issue of mask wearing has become the subject of some debate during the SARS-CoV-2 global pandemic. Opponents of mask wearing frequently cite the lack of high quality evidence specifically examining the effects of mask wearing on the spread of COVID-19. However, conducting such

idecabtagene vicleucel Treatment for Multiple Myeloma U.S. Food and Drug Administration (FDA) Accepts for Priority Review Bristol Myers Squibb and bluebird bio Application for Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleucel (Ide-cel, bb2121) Print this page PRINCETON, N.J., & CAMBRIDGE, Mass.–(BUSINESS WIRE) September 22, 2020 — Bristol Myers Squibb (NYSE: BMY) and bluebird bio, Inc.

Print this page NEW YORK–(BUSINESS WIRE) September 28, 2020 — Pfizer Inc. (NYSE: PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved Xeljanz® (tofacitinib) for the treatment of children and adolescents 2 years and older with active polyarticular course juvenile idiopathic arthritis (pcJIA). Two formulations were approved, a tablet and

Clinical review of cannabis hyperemesis syndrome describes the epidemiological and pathophysiological course of illness.  Cannabis, derived from the plant Cannabis sativa, is the most cultivated, trafficked, and used drug worldwide. Approximately 2.5% of the population consumes cannabis making it more rapidly abused than cocaine and opiates. Since the 1960s, its prevalence has surged exponentially in

Study shows that even moderate alcohol consumption is associated with high blood pressure, especially in patients with diabetes mellitus. Heavy alcohol consumption and its link to high blood pressure has been studied for a long time with early studies dating back to 1915. However, there have been conflicting reports on the risks and benefits of

Treatment for Seizure Clusters Aquestive Therapeutics Receives Complete Response Letter from FDA for Libervant (diazepam) Buccal Film for Management of Seizure Clusters Print this page WARREN, N.J., Sept. 25, 2020 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve

Print this page LAVAL, QC and DEER PARK, Ill., Sept. 25, 2020 /PRNewswire/ — Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”), Bausch + Lomb, a leading global eye health business, and Eton Pharmaceuticals, Inc. (NASDAQ: ETON) today announced that the U.S. Food and Drug Administration (FDA) has approved Alaway® Preservative Free (ketotifen fumarate) ophthalmic solution, 0.035%, antihistamine eye

Although it may not seem like it, the human bone structure is in a constant state of flux. Bones are continuously being broken down and rebuilt in a process known as bone metabolism. This process is controlled by the brain. As a result, certain mood disorders, such as depression, have been linked to bone abnormalities.

A new research study compares screen time with green time and how they impact children’s psychological outcomes. Mental health problems affect 1.2 million children in Canada under the age of 18, and the prevalence of mental illness is continuing to increase globally. Depression, anxiety, and other mental health problems in childhood can lead to poor

A study conducted at a major UK medical centre shows the risk of hospital staff contracting COVID-19 at the height of the coronavirus pandemic was lowest among intensive care staff. The occupational risk of exposure to SARS-CoV-2 has caused great concern since the beginning of the SARS-CoV-2 pandemic. Due to the nature of their work,

Researchers measured physiological and psychological changes in the body to investigate whether short simple massage techniques boost relaxation. The body’s mental and physical responses to stressful situations (such as increased heart rate, blood pressure, and brain alertness) are important for preparing the body for action. However, if these stress responses become chronic this can have

Print this page London UK 25 September 2020 — GlaxoSmithKline plc (GSK) today announced the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for the treatment of adult and pediatric patients aged 12 years and older with Hypereosinophilic Syndrome (HES) for ≥ six months without an identifiable non-hematologic secondary cause. The approval makes

September 23, 2020 Print this page Audience: Consumer, Health Professional, Pharmacy September 23, 2020 — Sun Pharmaceutical Industries, Inc. (Sun Pharma), a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. is voluntarily recalling one lot of Riomet ER™ (metformin hydrochloride for extended-release oral suspension), 500 mg per 5 mL to the consumer level. The reason